Maximal androgen blockade and neuroendocrine differentiation in prostate cancer patients. (CROSBI ID 487299)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Tarle, Marko ; Ahel, Zaky ; Spajić, Borislav ; Reljić, Ante ; Kraljić, Ivo ; Kovačić, Ksenija.
engleski
Maximal androgen blockade and neuroendocrine differentiation in prostate cancer patients.
The acquired CgA positivity is more pronounced with the prolonged hormonal treatment and is frequently related to the development of bone lesions. Thus during Mab continous serum CgA monitoring should be performed. These data raised the question related to the utility of intermittent prostate cancer hormonal therapy.
prostate cancer; Mab; NE differentiation; CgA level
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
52-52-x.
2001.
objavljeno
Podaci o matičnoj publikaciji
Book of Abstracts, 4th World Congress of Urological Research.
Kiprianou, Natasha et all.
Iowa City (IA): Society for Basic Urological Research
Podaci o skupu
4th World Congress in Urological Research
poster
29.11.2001-02.12.2001
Tucson (AZ), Sjedinjene Američke Države
